Calcium Channel Blocker and Hepatocellular Carcinoma Risk.
0/5 보강
APA
Lai SW (2025). Calcium Channel Blocker and Hepatocellular Carcinoma Risk.. Digestive diseases and sciences, 70(8), 2884-2885. https://doi.org/10.1007/s10620-025-09080-1
MLA
Lai SW. "Calcium Channel Blocker and Hepatocellular Carcinoma Risk.." Digestive diseases and sciences, vol. 70, no. 8, 2025, pp. 2884-2885.
PMID
40287910 ↗
같은 제1저자의 인용 많은 논문 (5)
- Lipid‑Lowering Agents and Hepatocellular Carcinoma Risk.
- Comment on "Lower glycemic status was associated with pancreatic cancer risk in prediabetes".
- Pancreatitis, Type 2 Diabetes Mellitus, and Pancreatic Cancer (Diabetes Metab J 2025;49:252-63).
- Antrocinol-mediated downregulation of ATG5 induces autophagy-dependent cell death and activates the unfolded protein response through PERK/CHOP signaling in lenvatinib-resistant hepatocellular carcinoma cells.
- New-onset diabetes mellitus and the risk of pancreatic cancer.